Clinical and pathological characteristics and outcomes of Chinese patients with primary anti-neutrophil cytoplasmic antibodies-associated systemic vasculitis with immune complex deposition in kidney

Nephrology

Volumn 12, Issue 1, 2007, Pages 74-80

  Yu, Feng ^a   Chen, Min ^a   Wang, Su Xia ^a   Zou, Wan Zhong ^a   Zhao, Ming Hui ^a   Wang, Hai Yan ^a  

^a PEKING UNIVERSITY FIRST HOSPITAL   (China)

Author keywords

Anti neutrophil cytoplasmic antibodies; Immune complex; Vasculitis

Indexed keywords

AZATHIOPRINE; CYCLOPHOSPHAMIDE; IMMUNOGLOBULIN M; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; NEUTROPHIL CYTOPLASMIC ANTIBODY; PREDNISONE;

ADULT; ARTICLE; CHINESE; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; DISEASE COURSE; FEMALE; HUMAN; HYPOCOMPLEMENTEMIA; IMMUNE COMPLEX DEPOSITION; IMMUNOGLOBULIN A NEPHROPATHY; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY FAILURE; LOW DRUG DOSE; MALE; MEMBRANOUS GLOMERULONEPHRITIS; MICROSCOPIC POLYANGIITIS; PREVALENCE; PRIORITY JOURNAL; PROTEINURIA; REMISSION; SYSTEMIC VASCULITIS; WEGENER GRANULOMATOSIS;

ADOLESCENT; ADULT; AGED; ANTIBODIES, ANTINEUTROPHIL CYTOPLASMIC; ANTIGEN-ANTIBODY COMPLEX; CHINA; CYCLOPHOSPHAMIDE; DRUG THERAPY, COMBINATION; FEMALE; FOLLOW-UP STUDIES; HUMANS; IMMUNOSUPPRESSIVE AGENTS; KIDNEY; MALE; MIDDLE AGED; PREDNISONE; RETROSPECTIVE STUDIES; TIME FACTORS; TREATMENT OUTCOME; VASCULITIS; WEGENER GRANULOMATOSIS;

EID: 33846975784     PISSN: 13205358     EISSN: 14401797     Source Type: Journal    
DOI: 10.1111/j.1440-1797.2006.00713.x     Document Type: Article

References (37)

1. Jennette JC, Falk R, Andrassy K et al. Nomenclature of systemic vasculitis: Proposal of an international consensus conference. Arthritis Rheum. 1994; 37: 187-92.
2. Haas M, Jafri J, Bartosh SM, Karp SL, Adler SG, Meehan SM. ANCA-associated crescentic glomerulonephritis with mesangial IgA deposits. Am. J. Kidney Dis. 2000; 36: 709-18.
3. Haas M, Eustace JA. Immune complex deposits in ANCA-associated crescentic glomerulonephritis: A study of 126 cases. Kidney Int. 2004; 65: 2145-52.
4. Neumann I, Regele H, Kain R, Birck R, Meisl FT. Glomerular immune deposits are associated with increased proteinuria in patients with ANCA-associated crescentic nephritis. Nephrol. Dial. Transplant. 2003; 18: 524-31.
5. Hunder GG, Arend WP, Bloch DA et al. The American College of Rheumatology 1990 criteria for the classification of vasculitis. Arthritis Rheum. 1990; 33: 1088-93.
6. Luqmani RA, Bacon PA, Moots RJ et al. Birmingham Vasculitis Activity Score (BVAS) in systemic necrotizing vasculitis. Q. J. Med. 1994; 87: 671-8.
7. Xin G, Zhao MH, Wang HY. Detection rate and antigenic specificities of antineutrophil cytoplasmic antibodies in Chinese patients with clinically suspected vasculitis. Clin. Diagn. Lab. Immunol. 2004; 11: 559-62.
8. Levey AS, Bosch JP, Rogers N, Roth D. A more accurate method to estimate glomerular filtration rate from serum creatinine: A new prediction equation. Ann. Intern. Med. 1999; 130: 461-70.
9. Bajema IM, Hagen EC, Hansen BE. The renal histopathology in systemic vasculitis: An international survey study of inter and intra-observer agreement. Nephrol. Dial. Transplant. 1996; 11: 989-95.
10. Franssen CFM, Stegeman CA, Oost-kort WW et al. Determinants of renal outcome in anti-myeloperoxidase-associated necrotizing crescentic glomerulonephritis. J. Am. Soc. Nephrol. 1998; 9: 1915-23.
11. Bajema IM, Hagen EC, Hermans J. Kidney biopsy as a predictor for renal outcome in ANCA-associated necrotizing glomerulonephritis. Kidney Int. 1999; 56: 1751-8.
12. Hauer HA, Bajema IM, Van Houwelingen HC et al. Renal histology in ANCA-associated vasculitis: Differences between diagnostic and serologic subgroup. Kidney Int. 2002; 61: 80-89.
13. Hauer HA, Bajema IM, Van Houwelingen HC et al. Determinants of outcome in ANCA-associated glomerulonephritis: A prospective clinico-histopathological analysis of 96 patients. Kidney Int. 2002; 62: 1732-42.
14. Nachman PH, Hogan SL, Jennette JC, Falk RJ. Treatment response and relapse in ANCA associated MPA and glomerulonephritis. J. Am. Soc. Nephrol. 1996; 7: 33-9.
15. Jennette JC, Thomas DB, Falk RJ. Microscopic polyangiitis (microscopic polyarteritis). Semin. Diagn. Pathol. 2001; 18: 3-13.
16. Brenner BM (ed.). The Kidney, 6th edn. Philadelphia: WB Saunders, 2000; 1322.
17. Wang Y, Zhao MH, Yu J et al. The clinical and pathological characteristics of Chinese elderly patients with anti-neutrophil cytoplasmic autoantibodies associated small vessel vasculitis. Exp. Gerontol. 2004; 39: 1401-5.
18. Hattori M, Kurayama H, Koitabashi Y. Antineutrophil cytoplasmic autoantibody-associated glomerulonephritis in children. J. Am. Soc. Nephrol. 2001; 12: 1493-500.
19. Hogan SL, Nachman PH, Wilkman AS. Prognostic markers in patients with antineutrophil cytoplasmic autoantibody-associated microscopic polyangiitis and glomerulonephritis. J. Am. Soc. Nephrol. 1996; 7: 23-32.
20. Jennette JC. Rapidly progressive glomerulonephritis. Kidney Int. 2002; 63: 1164-77.
21. Brenner BM (ed.). The Kidney, 6th edn. Philadelphia: WB Saunders, 2000; 1316.
22. Falk RJ, Jennette JC. ANCA small-vessel vasculitis. J. Am. Soc. Nephrol. 1997; 8: 314-22.
23. Ferrario F, Tadros MT, Napodano P, Sinico RA, Fellin G, d'Amico G. Critical reevaluation of 41 cases of 'idiopathic' crescentic glomerulonephritis. Clin. Nephrol. 1994; 41: 1-9.
24. Heeringa P, Brouwer E, Klok PA. Autoantibodies to myeloperoxidase aggravate mild anti-glomerular-basement membrane mediated glomerular injury. Am. J. Pathol. 1996; 146: 1695-706.
25. Brouwer E, Huitema MG, Klok PA. Anti-myeloperoxidase-associated proliferative glomerulonephritis: An animal model. J. Exp. Med. 1993; 177: 905-14.
26. Yang JJ, Jennette JC, Falk RJ. Immune complex glomerulonephritis is induced in rats immunized with heterogonous myeloperoxidase. Clin. Exp. Immunol. 1994; 97: 466-73.
27. Brons RH, de Jong MC, de Boer NK, Stegeman CA, Kallenberg CG, Cohen Tervaert JW. Detection of immune deposits in skin lesions of patients with Wegener's granulomatosis. Ann. Rheum. Dis. 2001; 60: 1097-102.
28. Tervaert JW, Heeringa P. Pathophysiology of ANCA-associated vasculitides: Are ANCA really pathogenic? Neth. J. Med. 2003; 61: 404-7.
29. Neumann I, Birck R, Newman M. SCG/Kinjoh mice: A model of ANCA-associated crescentic glomerulonephritis with immune deposits. Kidney Int. 2003; 64: 140-48.
30. Brons RH, Kallenberg CGM, Cohen Tervaert JW. Are neutrophil cytoplasmic antibody-associated vasculitides pauci-immune? Rheum. Dis. Clin. North Am. 2001; 27: 833-48.
31. Cochrane C, Weigle W, Dixon F. The role of polymorphonuclear leucocytes in the initiation and cessation of the Arthus vasculitis. J. Exp. Med. 1959; 110: 481-94.
32. Cream J, Bryceson A, Ryder G. Disappearance of immunoglobulin and complement from the Arthus reaction and its relevance to studies of vasculitis in man. Br. J. Dermatol. 1971; 84: 106-9.
33. Yu F, Zhao MH, Zhang YK, Zhang Y, Wang HY. Anti-endothelial cell antibodies (AECA) in patients with propylthiouracil (PTU) induced ANCA positive vasculitis are associated with disease activity. Clin. Exp. Immunol. 2005; 139: 569-74.
34. Stegeman CA, Cohen Terbvaert JW, Manson WL, Sluiter WJ, de Jong PE, Kallenberg CGM. Chronic nasal carriage of Staphylococcal aureus in Wegener's granulomatoses identifies a subgroup of patients more prone to relapses. Ann. Intern. Med. 1994; 120: 12-17.
35. Stegeman CA, Cohen Terbvaert JW, de Jong PE, Kallenberg CGM. Trimethoprim-sulfamethoxazole for the prevention of relapses of Wegener's granulomatoses. N. Engl. J. Med. 1996; 335: 16-20.
36. Cohen Tervaert JW, Popa ER, Brons RH. Staphylococcus aureus, superantigens and vasculitis. Clin. Exp. Immunol. 2000; 120 (Suppl. 1): 6.
37. Brons RH, Tiebosch AT, Stegeman CA, Cohen Terbvaert JW. Detection of a staphylococcal antigen in renal biopsies of patients with WG. Clin. Exp. Immunol. 2000; 120 (Suppl. 1): 47.